Skip to main content
. 2021 Sep 17;221(10):592–595. doi: 10.1016/j.rceng.2021.02.005

Table 1.

Characteristics of patients who received dexamethasone.

1 2 3 4 5 6 7 8
Age 57 33 56 56 73 70 57 56
Sex Female Men Female Men Female Female Men Female
Dexamethasone dose (mg/day) 6 6 6 6 6 6 6 6
Days of treatment before admission 5 3 6 4 4 5 4 5
PaO2/FiO2 (mmHg) 305 310 310 324 305 310 305 310
HRCT Involvement Severe Severe Moderate Not performed Severe Not performed Severe Severe
Ferritin (µg/L) 378 181 335 579 385 413 133 881
D-dimer (mg/L) 0,29 0.41 1.6 0.25 0.56 0.33 0.7 0.6
CRP (mg/dL) 205 21 35 63 25 25 133 72
Treatment 6MP pulses 6MP pulses 6MP pulses 6MP pulses Dexamethasone 6MP pulses 6MP pulses 6MP pulses
HFNO Anakinra HFNO HFNO

HNFO: high-flow nasal oxygen; CRP: C-reactive protein; HRCT: high resolution computed tomography; 6MP: 6-methylprednisolone.